Attention AACR Annual Meeting 2018 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Biosimilars: Biological Science, Regulatory Science, and Clinical Practice

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Biosimilar biologic products: The US FDA perspective
Joseph Franklin
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Biologic complexity: Implications for biosimilar development
Simon Hotchin
Amgen, Inc., Thousand Oaks, CA, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Biosimilar development: Clinical implications and applications
Sara A Hurvitz
UCLA, Santa Monica, CA, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Biosimilar regulatory policy: Understanding the landscape and relevance to medical practice
Sue Lim
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4